Sernova Update on Strategic Initiatives

GlobeNewswireDec 2 08:00 ET

Sernova (SVA) Gets a Buy From Ventum Financial

TipRanksSep 13 16:05 ET · Ratings

Sernova Corp. Price Target Cut to C$2.50/Share From C$3.00 by Ventum Financial

Dow JonesSep 13 11:49 ET · Ratings

Sernova Corp. Is Maintained at Buy by Ventum Financial

Dow JonesSep 13 11:49 ET · Ratings

Sernova Corp Launches $4 Million Private Placement

TipRanksAug 20 08:18 ET

Sernova Announces Additional Patient Insulin Independent and Cohort 2 Enrollment Complete in Ongoing Phase I/II Clinical Trial for Treatment of Type 1 Diabetes

Stockhouse Jun 25 07:00 ET